Discovery Group I’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$38.6M Sell
2,089,974
-79,755
-4% -$1.38M 14.72% 1
2017
Q2
$35.9M Buy
2,169,729
+233,920
+12% +$3.25M 10.38% 1
2017
Q1
$26.7M Buy
1,935,809
+1,189,826
+159% +$19.1M 8.91% 3
2016
Q4
$14.2M Buy
745,983
+45,698
+7% +$877K 5.52% 6
2016
Q3
$15.5M Buy
+700,285
New +$13.2M 6.36% 6

Other funds holding ENTL

Discovery Group I's ENTL Position: Q3 2017 in Review

Discovery Group I reduced its Entellus Medical, Inc. Common Stock (ENTL) stake by 3.7% in Q3 2017, selling an estimated $1.38M and leaving 2,089,974 shares worth $38.6M. The position accounts for 14.72% of the portfolio, ranked #1.

Discovery Group I first reported a position in ENTL in Q3 2016 and has held it in 5 quarters since. 72 funds tracked by Wall St. Rank hold ENTL as of Q3 2017.

  • Discovery Group I held 2,089,974 shares of Entellus Medical, Inc. Common Stock worth $38.6M as of Q3 2017.
  • Discovery Group I sold 79,755 Entellus Medical, Inc. Common Stock shares in Q3 2017, an estimated $1.38M.
  • Entellus Medical, Inc. Common Stock made up 14.72% of Discovery Group I's portfolio in Q3 2017, its #1 holding.
  • Discovery Group I first reported a position in Entellus Medical, Inc. Common Stock in Q3 2016 and has held it in 5 quarters since.
  • 72 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q3 2017.

Based on Discovery Group I's 13F filing for Q3 2017, filed 13 Nov 2017.